维普期刊资源整合服务平台（V6.5）

196篇 您的检索式：作者名="SAKU K"

选中清除导出查看参考文献查看引证文献引用追踪共10页首页上一页第1页下一页末页 /10 跳转

	题名	作者	年代	出处	被引量
1	The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model显示文摘	Kumagai K Nakashima H Saku K	2004	Cardiovasc Res2004，62，1：	1
2	The HMG2CoA reduetase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditismodel 显示文摘	Kumagai K Nakashima H Saku K	2004	Cadiovasc Res2004，62，1：	1
3	Deposition af oxidized low-&nsity lipoprotein and collagenosis occur coincidentally in human coronary stenosis :an immunohistochemical study of atherectomy 显示文摘	Jir6 S Saku K Kusaba H	1998	Coron Artery Dis1998，9，9：	1
4	The HMG-COA reductase inhibitor atorvastatin revents atrial fibrillation by inhibiting inflammation in a canine sterile eriearditis model显示文摘	Kumagai K Nakashima H Saku K	2004	Cardiovasc Res2004，62，1：	1
5	Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in hu-man coronary endothelial cells 显示文摘	Miura S Matsuo Y Saku K	2003	Hypertension2003，41，：	1
6	High-density iipoprotein and apolipoprotein A-I deficiency induced by combination therapy with probueol and bezafibrate显示文摘	Saku K Zhang B Jimi S	1995	Eur J Clin Pharmacol1995，48，34：	1
7	Insulin resistance and angiographical characteristics of coronary atherosclerosis显示文摘	Takezako T Saku K Zhang B		0，，：	1
8	Levela of soluble adhesion molecules in patiems with angiographically defined coronary atherosclerosis显示文摘	Saku K Zhang B	1999	Jpn Ciec J1999，63，1：	1
9	The HMG-CoA reductase inhibitor atorvaatatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model显示文摘	Kumagai K Nakashima H Saku K	2004	Cardiovasc Res2004，62，1：	1
10	Constitutively active homooligomeric angiotensin II type 2 receptor induces cell signaling independent of receptor conformation and ligand stimulation 显示文摘	Miura S Karnik S S Saku K	2005	J Biol Chem2005，280，18：	1
11	The HMG-CoA reductase inhibitor atorvastatinprevents atrial fibrillation by inhibiting infammation in a canine sterile sterile pericarditis model显示文摘	Kumagai K Nakasshima H Saku K	2004	Cardiovasc Res2004，62，1：	1
12	Randomized head-to-head comparison of pitavastatin,atorvastatin,and rosuvastatin for safety and efficacy(quantity and quality of LDL):the PATROL显示文摘	Saku K Zhang B Noda K		0，，：	1
13	Randomized head-to-head comparison of pitavastatin atorvastatin and rosuvastatin for safety and efficacy(quantity and quality of LDL)-the PATROL trial显示文摘	Saku K Zhang B Noda K	2011	Circ J2011，75，6：	1
14	The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model显示文摘	KUMAGAI K NAKASHIMA H SAKU K	2004	Cardiovasc Res2004，62，：	1
15	Efficacy and safety of angiotensin H type 1receptor blocker/calcium channel blocker combination therapy forhypertension j focus on a single-pill fixed-dose combination of val-sartan and amIodipine显示文摘	Miura S Saku K	2012	J Int Med Res2012，40，1：	1
16	The HMG-CoA red-uctase inhibitor atorvastatin prevents atrial fibrillation by inhi-biting inflammation in a canine sterile pericarditis model显示文摘	Kumagai K Nakashima H Saku K		0，，：	1
17	Progressive motor deficits in lacunar infarction显示文摘	Nakamura K Saku Y Ibayashi S	1999	Neurology1999，52，：	1
18	The HMG - CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting in- flammation in a canine sterile pericarditis model 显示文摘	Kumagai K Nakashima H Saku K	2004	Cardiovasc Res2004，62，1：	1
19	The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model显示文摘	KUMAGAI K NAKASHIMA H SAKU K	2004	Cardiovase Res2004，62，：	1
20	Disturbances of fluid and electrolyte balance in patients with acute stroke显示文摘	Kusuda K Saku Y Sadoshima S	1989	Nippon Ronen Igakkai Zasshi1989，3223，：	1

返回顶部每页显示：

共10页首页上一页第1页下一页末页 /10 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示